The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Active targeting of gold nanoparticles as cancer therapeutics
Open accessAbstract
Gold nanoparticles are excellent delivery systems, but how can we get them where we want them to go?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El-Sayed, M. A. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15237h · Cited by 3,550
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Eustis, S., & El-Sayed, M. A. (2006) · Chem. Soc. Rev. · doi:10.1039/b514191e · Cited by 3,143
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity
Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J., & Wyatt, M. D. (2005) · Small · doi:10.1002/smll.200400093 · Cited by 2,406
Plasmonic photothermal therapy (PPTT) using gold nanoparticles
Huang, X., Jain, P. K., El-Sayed, I. H., & El-Sayed, M. A. (2008) · Lasers in Medical Science · doi:10.1007/s10103-007-0470-x · Cited by 2,376
Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
Jayasena, S. D. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1628 · Cited by 2,144
Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery
Liong, M., Lu, J., Kovochich, M., Xia, T., Ruehm, S. G., Nel, A. E., Tamanoi, F., & Zink, J. I. (2008) · ACS Nano · doi:10.1021/nn800072t · Cited by 1,929
Shape control in gold nanoparticle synthesis
Grzelczak, M., Pérez-Juste, J., Mulvaney, P., & Liz-Marzán, L. M. (2008) · Chemical Society Reviews · doi:10.1039/b711490g · Cited by 1,911
Cetuximab for the Treatment of Colorectal Cancer
Jonker, D. J., O'Callaghan, C. J., Karapetis, C. S., Zalcberg, J. R., Tu, D., Au, H.-J., Berry, S. R., Krahn, M., Price, T., Simes, R. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071834 · Cited by 1,904
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879
Hostetler, M. J., Wingate, J. E., Zhong, C.-J., Harris, J. E., Vachet, R. W., Clark, M. R., Londono, J. D., Green, S. J., Stokes, J. J., Wignall, G. D., et al. (1998) · Langmuir · doi:10.1021/la970588w · Cited by 1,835
Cetuximab in the treatment of colorectal cancer.
Goldberg, R. M., Venook, A. P., & Schilsky, R. L. (2004) · PubMed · Cited by 1,518
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Therapeutic antibodies: successes, limitations and hopes for the future
Chames, P., Van Regenmortel, M., Weiss, E., & Baty, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00190.x · Cited by 1,382
PEG-modified gold nanorods with a stealth character for in vivo applications
Niidome, T., Yamagata, M., Okamoto, Y., Akiyama, Y., Takahashi, H., Kawano, T., Katayama, Y., & Niidome, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.017 · Cited by 1,200
Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects
Begines, B., Ortiz, T., Pérez-Aranda, M., Martínez, G., Merinero, M., Argüelles-Arias, F., & Alcudia, A. (2020) · Nanomaterials · doi:10.3390/nano10071403 · Cited by 1,061
Inorganic nanoparticles as carriers for efficient cellular delivery
Xu, Z. P., Zeng, Q. H., Lu, G. Q., & Yu, A. B. (2006) · Chemical Engineering Science · doi:10.1016/j.ces.2005.06.019 · Cited by 976
State of the art in gold nanoparticle synthesis
Zhao, P., Li, N., & Astruc, D. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.09.002 · Cited by 964
Biological properties of “naked” metal nanoparticles☆
BHATTACHARYA, R., & MUKHERJEE, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.013 · Cited by 917
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Brown, S. D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P. R., Venugopal, B., Flint, D. J., Plumb, J. A., Graham, D., & Wheate, N. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908117a · Cited by 865
Gold nanostructures: a class of multifunctional materials for biomedical applications
Cobley, C. M., Chen, J., Cho, E. C., Wang, L. V., & Xia, Y. (2011) · Chem. Soc. Rev. · doi:10.1039/b821763g · Cited by 792
Kim, D., Jeong, Y. Y., & Jon, S. (2010) · ACS Nano · doi:10.1021/nn901877h · Cited by 726
Ma, X., Wu, Y., Jin, S., Tian, Y., Zhang, X., Zhao, Y., Yu, L., & Liang, X.-J. (2011) · ACS Nano · doi:10.1021/nn202155y · Cited by 628
Liposomal Drug Delivery Systems and Anticancer Drugs
Olusanya, T., Haj Ahmad, R., Ibegbu, D., Smith, J., & Elkordy, A. (2018) · Molecules · doi:10.3390/molecules23040907 · Cited by 603
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Sun, H., Zhu, X., Lu, P. Y., Rosato, R. R., Tan, W., & Zu, Y. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.32 · Cited by 541
Camelid immunoglobulins and nanobody technology
Muyldermans, S., Baral, T. N., Retamozzo, V. C., De Baetselier, P., De Genst, E., Kinne, J., Leonhardt, H., Magez, S., Nguyen, V. K., Revets, H., et al. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2008.10.299 · Cited by 533
Review of the methodologies used in the synthesis gold nanoparticles by chemical reduction
Daruich De Souza, C., Ribeiro Nogueira, B., & Rostelato, M. E. C. M. (2019) · Journal of Alloys and Compounds · doi:10.1016/j.jallcom.2019.05.153 · Cited by 508
Austin, C. D., De Mazière, A. M., Pisacane, P. I., van Dijk, S. M., Eigenbrot, C., Sliwkowski, M. X., Klumperman, J., & Scheller, R. H. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0591 · Cited by 496
Van de Broek, B., Devoogdt, N., D’Hollander, A., Gijs, H.-L., Jans, K., Lagae, L., Muyldermans, S., Maes, G., & Borghs, G. (2011) · ACS Nano · doi:10.1021/nn1023363 · Cited by 374
Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
Patra, C. R., Bhattacharya, R., Wang, E., Katarya, A., Lau, J. S., Dutta, S., Muders, M., Wang, S., Buhrow, S. A., Safgren, S. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6102 · Cited by 371
Wang, J., Zhu, G., You, M., Song, E., Shukoor, M. I., Zhang, K., Altman, M. B., Chen, Y., Zhu, Z., Huang, C. Z., et al. (2012) · ACS Nano · doi:10.1021/nn300694v · Cited by 357
Stuchinskaya, T., Moreno, M., Cook, M. J., Edwards, D. R., & Russell, D. A. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05014a · Cited by 329
Self-citationDiscovery and Development of Therapeutic Aptamers
Bouchard, P. R., Hutabarat, R. M., & Thompson, K. M. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105547 · Cited by 320
Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment
Kumar, A., Ma, H., Zhang, X., Huang, K., Jin, S., Liu, J., Wei, T., Cao, W., Zou, G., & Liang, X.-J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.058 · Cited by 315
Gao, J., Huang, X., Liu, H., Feng, Z., & Ren, J. (2012) · Langmuir · doi:10.1021/la204289k · Cited by 314
Tumor detection using folate receptor-targeted imaging agents
Sega, E. I., & Low, P. S. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9155-6 · Cited by 291
Ruan, S., Cao, X., Cun, X., Hu, G., Zhou, Y., Zhang, Y., Lu, L., He, Q., & Gao, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.006 · Cited by 290
Carbon dots as a trackable drug delivery carrier for localized cancer therapy in vivo
Zeng, Q., Shao, D., He, X., Ren, Z., Ji, W., Shan, C., Qu, S., Li, J., Chen, L., & Li, Q. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01259k · Cited by 289
Wang, S., Chen, K., Wu, T., Wang, H., Lin, W., Ohashi, M., Chiou, P., & Tseng, H. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000062 · Cited by 268
The roles of nucleolin subcellular localization in cancer
Berger, C. M., Gaume, X., & Bouvet, P. (2015) · Biochimie · doi:10.1016/j.biochi.2015.03.023 · Cited by 267
Design Strategies for Aptamer-Based Biosensors
Han, K., Liang, Z., & Zhou, N. (2010) · Sensors · doi:10.3390/s100504541 · Cited by 264
Efficient tumor targeting by single‐domain antibody fragments of camels
Cortez‐Retamozo, V., Lauwereys, M., Hassanzadeh Gh., G., Gobert, M., Conrath, K., Muyldermans, S., De Baetselier, P., & Revets, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10212 · Cited by 260
Pharmacokinetics of metallic nanoparticles
Lin, Z., Monteiro‐Riviere, N. A., & Riviere, J. E. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1304 · Cited by 257
An Overview of the Synthesis of Gold Nanoparticles Using Radiation Technologies
Freitas de Freitas, L., Varca, G. H. C., Dos Santos Batista, J. G., & Benévolo Lugão, A. (2018) · Nanomaterials · doi:10.3390/nano8110939 · Cited by 235
Release of Photoactivatable Drugs from Plasmonic Nanoparticles for Targeted Cancer Therapy
Luo, Y.-L., Shiao, Y.-S., & Huang, Y.-F. (2011) · ACS Nano · doi:10.1021/nn201592s · Cited by 233
Plectin-1 as a Novel Biomarker for Pancreatic Cancer
Bausch, D., Thomas, S., Mino-Kenudson, M., Fernández-del, C. C., Bauer, T. W., Williams, M., Warshaw, A. L., Thayer, S. P., & Kelly, K. A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0999 · Cited by 226
A review on gold nanoparticles radiosensitization effect in radiation therapy of cancer
Mesbahi, A. (2010) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2010.09.001 · Cited by 221
Wang, X., Cai, X., Hu, J., Shao, N., Wang, F., Zhang, Q., Xiao, J., & Cheng, Y. (2013) · Journal of the American Chemical Society · doi:10.1021/ja402903h · Cited by 213
Association with Membrane Protrusions Makes ErbB2 an Internalization-resistant Receptor
Hommelgaard, A. M., Lerdrup, M., & van Deurs, B. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-08-0596 · Cited by 210
Targeting tumors with nanobodies for cancer imaging and therapy
Oliveira, S., Heukers, R., Sornkom, J., Kok, R. J., & van Bergen en Henegouwen, P. M. P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.298 · Cited by 206
Endogenous lectins as targets for drug delivery
Yamazaki, N., Kojima, S., Bovin, N. V., André, S., Gabius, S., & Gabius, H.-J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00071-5 · Cited by 200
Multifunctional Nanocarriers for Cell Imaging, Drug Delivery, and Near-IR Photothermal Therapy
Guo, R., Zhang, L., Qian, H., Li, R., Jiang, X., & Liu, B. (2010) · Langmuir · doi:10.1021/la903893n · Cited by 188
Liang, G., Jin, X., Zhang, S., & Xing, D. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.017 · Cited by 180
Gold-doxorubicin nanoconjugates for overcoming multidrug resistance
Gu, Y.-J., Cheng, J., Man, C. W.-Y., Wong, W.-T., & Cheng, S. H. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.06.005 · Cited by 171
Carnovale, C., Bryant, G., Shukla, R., & Bansal, V. (2016) · Progress in Materials Science · doi:10.1016/j.pmatsci.2016.04.003 · Cited by 169
Liang, S., Li, C., Zhang, C., Chen, Y., Xu, L., Bao, C., Wang, X., liu, G., zhang, F., & Cui, D. (2015) · Theranostics · doi:10.7150/thno.11632 · Cited by 167
Bourguignon, L., Lokeshwar, V. B., Chen, X., & Kerrick, W. G. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.12.6634 · Cited by 162
Kumar, A., Huo, S., Zhang, X., Liu, J., Tan, A., Li, S., Jin, S., Xue, X., Zhao, Y., Ji, T., et al. (2014) · ACS Nano · doi:10.1021/nn500152u · Cited by 162
Chattopadhyay, N., Cai, Z., Kwon, Y. L., Lechtman, E., Pignol, J.-P., & Reilly, R. M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2338-4 · Cited by 162
Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery
Karve, S., Werner, M. E., Sukumar, R., Cummings, N. D., Copp, J. A., Wang, E. C., Li, C., Sethi, M., Chen, R. C., Pacold, M. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120508109 · Cited by 154
Peptide-Targeted Gold Nanoparticles for Photodynamic Therapy of Brain Cancer
Meyers, J. D., Cheng, Y., Broome, A., Agnes, R. S., SCHLUCHTER, M. D., Margevicius, S. P., Wang, X., Kenney, M. E., Burda, C., & Basilion, J. P. (2014) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201400119 · Cited by 148
Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis
Bhattacharyya, S., Bhattacharya, R., Curley, S. A., McNiven, M. A., & Mukherjee, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006507107 · Cited by 147
Seeing, Targeting and Delivering with Upconverting Nanoparticles
Jalani, G., Tam, V. H., Vetrone, F., & Cerruti, M. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b03977 · Cited by 142
Obaid, G., Chambrier, I., Cook, M. J., & Russell, D. A. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c4pp00312h · Cited by 141
Self-citationShape-dependent antibacterial effects of non-cytotoxic gold nanoparticles
Penders, J., Stolzoff, M., Hickey, D. J., Andersson, M., & Webster, T. J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s124442 · Cited by 141
Banu, H., Sethi, D. K., Edgar, A., Sheriff, A., Rayees, N., Renuka, N., Faheem, S. M., Premkumar, K., & Vasanthakumar, G. (2015) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2015.05.008 · Cited by 139
Chattopadhyay, N., Cai, Z., Pignol, J., Keller, B. M., Lechtman, E., Bendayan, R., & Reilly, R. M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100207t · Cited by 137
Galectins as Molecular Targets for Therapeutic Intervention
Dings, R. P. M., Miller, M. C., Griffin, R. J., & Mayo, K. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030905 · Cited by 136
Wu, P., Onodera, Y., Ichikawa, Y., Rankin, E. B., Giaccia, A. J., Watanabe, Y., Qian, W. P., Hashimoto, T., Shirato, H., & Nam, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s137833 · Cited by 134
Yi, Y., Kim, H. J., Zheng, M., Mi, P., Naito, M., Kim, B. S., Min, H. S., Hayashi, K., Perche, F., Toh, K., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.006 · Cited by 131
Cheng, Y., Meyers, J. D., Agnes, R. S., Doane, T. L., Kenney, M. E., Broome, A., Burda, C., & Basilion, J. P. (2011) · Small · doi:10.1002/smll.201100628 · Cited by 130
Novel ligands for the affinity-chromatographic purification of antibodies
Fassina, G., Ruvo, M., Palombo, G., Verdoliva, A., & Marino, M. (2001) · Journal of Biochemical and Biophysical Methods · doi:10.1016/s0165-022x(01)00215-9 · Cited by 128
Lee, H., Dam, D. H. M., Ha, J. W., Yue, J., & Odom, T. W. (2015) · ACS Nano · doi:10.1021/acsnano.5b05138 · Cited by 121
Calavia, P. G., Chambrier, I., Cook, M. J., et al. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.10.030 · Cited by 116
Kumar, C. S., Raja, M. D., Sundar, D. S., Antoniraj, M. G., & Kandasamy, R. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.04.010 · Cited by 111
Spadavecchia, J., Movia, D., Moore, C., Maguire, C. M., Moustaoui, H., Casale, S., Volkov, Y., & Prina‐Mello, A. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s97476 · Cited by 108
Lotan, R., & Raz, A. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb22372.x · Cited by 106
Popovtzer, A., Mizrachi, A., Motiei, M., Bragilovski, D., Lubimov, L., Levi, M., Hilly, O., Ben‐Aharon, I., & Popovtzer, R. (2016) · Nanoscale · doi:10.1039/c5nr07496g · Cited by 106
Penon, O., Marín, M. J., Russell, D. A., & Pérez‐García, L. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.02.006 · Cited by 104
Self-citationYi, Y., Kim, H. J., Mi, P., Zheng, M., Takemoto, H., Toh, K., Kim, B. S., Hayashi, K., Naito, M., Matsumoto, Y., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.041 · Cited by 101
Ghahremani, F. H., Shahbazi‐Gahrouei, D., Kefayat, A., Motaghi, H., Mehrgardi, M. A., & Javanmard, S. H. (2018) · RSC Advances · doi:10.1039/c7ra11116a · Cited by 98
Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma
Niu, G., Sun, X., Cao, Q., Courter, D. L., Koong, A. C., Le, Q., Gambhir, S. S., & Chen, X. S. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2495 · Cited by 95
Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy
Ramesh, R., Amreddy, N., Muralidharan, R., Babu, A., Mehta, M., Johnson, E. V., Munshi, A., & Zhao, Y. D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s93237 · Cited by 92
Melancon, M. P., Lü, W., & Li, C. (2009) · MRS Bulletin · doi:10.1557/mrs2009.117 · Cited by 86
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
Čihorić, N., Savić, S., Schneider, S. S., Ackermann, I., Bichsel-Naef, M., Schmid, R. A., Lardinois, D., Gugger, M., Bubendorf, L., Zlobec, I., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.229 · Cited by 82
Guo, J., O’Driscoll, C. M., Holmes, J. D., & Rahme, K. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.05.027 · Cited by 82
HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer
Kubota, T., Kuroda, S., Kanaya, N., Morihiro, T., Aoyama, K., Kakiuchi, Y., Kikuchi, S., Nishizaki, M., Kagawa, S., Tazawa, H., et al. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.05.019 · Cited by 82
Ai, J., Xu, Y., Lou, B., Li, D., & Wang, E. (2013) · Talanta · doi:10.1016/j.talanta.2013.09.062 · Cited by 81
DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics
Latorre, A., Posch, C., Garcimartín, Y., Celli, A., Sanlorenzo, M., Vujic, I., Ma, J. A., Zekhtser, M., Rappersberger, K., Ortiz‐Urda, S., et al. (2014) · Nanoscale · doi:10.1039/c4nr00019f · Cited by 81
Taghdisi, S. M., Danesh, N. M., Lavaee, P., Emrani, A. S., Hassanabad, K. Y., Ramezani, M., & Abnous, K. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.01.009 · Cited by 81
Song, L., Falzone, N., & Vallis, K. A. (2016) · International Journal of Radiation Biology · doi:10.3109/09553002.2016.1145360 · Cited by 81
Cai, Z., Yook, S., Lu, Y., Bergstrom, D., Winnik, M. A., Pignol, J., & Reilly, R. M. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2082-2 · Cited by 81
Kao, H.-W., Lin, Y.-Y., Chen, C., Chi, K., Tien, D., Hsia, C.-C., Lin, M.-H., & Wang, H. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.04.002 · Cited by 79
Zhang, M., Kim, H. S., Jin, T., & Moon, W. K. (2017) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2017.03.025 · Cited by 79
Dreaden, E. C., Gryder, B. E., Austin, L. A., Defo, B. A. T., Hayden, S. C., Pi, M., Quarles, L. D., Oyelere, A. K., & El‐Sayed, M. A. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300158k · Cited by 75
Bassett, E. W., Tanenbaum, S. W., Pryzwansky, K. B., Beiser, S. M., & Kabat, E. A. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.122.2.251 · Cited by 74
Synthesis and bioanalytical applications of specific-shaped metallic nanostructures: A review
Tokonami, S., Yamamoto, Y., Shiigi, H., & Nagaoka, T. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.12.025 · Cited by 71
Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles
Tummala, S., Kumar, M. N. S., & Pindiprolu, S. K. S. S. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1199606 · Cited by 71
Saber, M. M., Bahrainian, S., Dinarvand, R., & Atyabi, F. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.016 · Cited by 70
Feng, B., Xu, Z., Zhou, F., Yu, H., Sun, Q., Dangge, W., Tang, Z., Yu, H., Yin, Q., Zhang, Z., et al. (2015) · Nanoscale · doi:10.1039/c5nr03693c · Cited by 66
Pal, K., Al-suraih, F., González-Rodríguez, R., Dutta, S. K., Wang, E., Kwak, H. S., Caulfield, T. R., Coffer, J. L., & Bhattacharya, S. (2017) · Nanoscale · doi:10.1039/c7nr03172f · Cited by 64
Camerin, M., Moreno, M., Marín, M. J., Schofield, C. L., Chambrier, I., Cook, M. J., Coppellotti, O., Jori, G., & Russell, D. A. (2016) · Photochemical & Photobiological Sciences · doi:10.1039/c5pp00463b · Cited by 60
Self-citationEnhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide
Biscaglia, F., Rajendran, S., Conflitti, P., Benna, C., Sommaggio, R., Litti, L., Mocellin, S., Bocchinfuso, G., Rosato, A., Palleschi, A., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700596 · Cited by 59
Keil, J. M., Seo, J., Howell, M. D., Hsu, W. H., Singh, R. N., & DiDonato, C. J. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.23 · Cited by 59
Luan, X., Rahme, K., Cong, Z., Wang, L., Zou, Y., He, Y., Yang, H., Holmes, J. D., O’Driscoll, C. M., & Guo, J. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.02.013 · Cited by 59
Mohamed, M. S., Veeranarayanan, S., Poulose, A. C., Nagaoka, Y., Minegishi, H., Yoshida, Y., Maekawa, T., & Kumar, D. S. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.020 · Cited by 58
Lee, K. Y. J., Wang, Y., & Nie, S. (2015) · RSC Advances · doi:10.1039/c5ra09872f · Cited by 50
Jo, H., Youn, H., Lee, S., & Ban, C. (2014) · J. Mater. Chem. B · doi:10.1039/c4tb00643g · Cited by 49
Cancer-targeted photothermal therapy using aptamer-conjugated gold nanoparticles
Hong, E. J., Kim, Y.-S., Choi, D. G., & Shim, M. S. (2018) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2018.07.017 · Cited by 46
Xu, X., Zhao, L., Li, X., Wang, P., Zhao, J., Shi, X., & Shen, M. (2017) · Biomaterials Science · doi:10.1039/c7bm00826k · Cited by 45
Ngernyuang, N., Seubwai, W., Daduang, S., Boonsiri, P., Limpaiboon, T., & Daduang, J. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.11.062 · Cited by 43
Targeting Nanocarriers with Anisamide: Fact or Artifact?
Dasargyri, A., Kümin, C. D., & Leroux, J. (2016) · Advanced Materials · doi:10.1002/adma.201603451 · Cited by 42
Yin, H., Mai, D.-S., Gan, F., & Chen, X. (2014) · RSC Advances · doi:10.1039/c3ra47729k · Cited by 35
Otlewski, J., Szlachcic, Pala, Zakrzewska, Jakimowicz, & Wiedlocha (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s36575 · Cited by 34
Jha, S., Ramadori, F., Quarta, S., Biasiolo, A., Fabris, E., Baldan, P., Guarino, G., Ruvoletto, M., Villano, G., Turato, C., et al. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00441 · Cited by 31
MUC1-Targeted Cancer Cell Photothermal Ablation Using Bioinspired Gold Nanorods
Zelasko-Leon, D. C., Fuentes, C., & Messersmith, P. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128756 · Cited by 30
Avvakumova, S., Galbiati, E., Pandolfi, L., Mazzucchelli, S., Cassani, M., Gori, A., Longhi, R., & Prosperi, D. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500202b · Cited by 20
Das, A., Soehnlen, E. S., Woods, S. M., Hegde, R., Henry, A. J., Gericke, A., & Basu, S. (2011) · Journal of Nanoparticle Research · doi:10.1007/s11051-011-0300-8 · Cited by 12
Bombesin‐functionalized water‐soluble gold nanoparticles for targeting prostate cancer
Simpson, E. J., Gobbo, P., Bononi, F. C., Murrell, E., Workentin, M. S., & Luyt, L. G. (2017) · Journal of Interdisciplinary Nanomedicine · doi:10.1002/jin2.33 · Cited by 6
Development of 170Tm‐DOTA‐cetuximab for radioimmunotherapy
Shirvani‐Arani, S., Bahrami‐Samani, A., Jalilian, A. R., Shirvani‐Arani, A., & Ghannadi‐Maragheh, M. (2012) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1957 · Cited by 5
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
“283,284 Inert surface chemistry of gold allows limited interactions at nano-bio interface and consequently leads to high cellular and tissue compatibility.”
BackgroundOvercoming barriers in photodynamic therapy harnessing nano-formulation strategies
Xie, J., Wang, Y., Choi, W., Jangili, P., Ge, Y., Xu, Y., Kang, J., Liu, L., Zhang, B., Xie, Z., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01370f · Cited by 522
Kus-Liśkiewicz, M., Fickers, P., & Ben Tahar, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010952 · Cited by 404
Botteon, C. E. A., Silva, L. B., Ccana-Ccapatinta, G. V., Silva, T. S., Ambrosio, S. R., Veneziani, R. C. S., Bastos, J. K., & Marcato, P. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-81281-w · Cited by 267
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Qian, L., Lin, X., Gao, X., Khan, R. U., Liao, J.-Y., Du, S., Ge, J., Zeng, S., & Yao, S. Q. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00915 · Cited by 155
Metadata
- Authors
- Goddard, Z. R., Marín, M. J., Russell, D. A., & Searcey, M.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2020
- Volume
- 49
- Issue
- 23
- Pages
- 8774-8789
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W3093860619
- Cited by
- 282
- References
- 127
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.